Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous gentamicin to reduce cesarean section wound infection
IRCT20221126056607N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Nov 2022
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of gentamicin in surgical site infection (SSI), sponsored by Qom University of Medical Sciences. Primary endpoint: Incidence of cesarean section wound infection. Started Nov 2022; status: completed.
02
Drugs
gentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20221126056607N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221126056607N1.